Predict your next investment

Government
salute.gov.it/portale/p5_11.jsp

See what CB Insights has to offer

Investments

3

About Italy Ministry of Health

Italy Ministry of Health is a governmental agency.

Italy Ministry of Health Headquarter Location

Italy

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Italy Ministry of Health News

Applied DNA Sciences : COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models

Mar 18, 2020

03/02 03/02 0 Message : *Required fields Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA”) today announced that its COVID-19 collaboration partner, Takis Biotech, a Rome, Italy-based a company focused on the development of cancer vaccines founded by scientists from Merck Research Laboratories, has received approval from the Italy’s Ministry of Health to begin a pre-clinical trial of a COVID-19 vaccine candidate. As announced by Applied DNA on March 2, 2020 , the vaccine is one of four PCR-produced (polymerase chain reaction vaccine) linear DNA vaccine candidates under joint development by Takis Biotech and Applied DNA. Applied DNA entered large-scale production of the candidates in March 2020. Takis Biotech anticipates first results of its pre-clinical trial will be available in April 2020. Click here to read Takis Biotech’s announcement (in English and Italian): http://www.takisbiotech.it/index.php/en/news/209-rome-17-march-2020-takis-a-biotech-company-in-castel-romano-rome-announces-that-it-is-ready-to-test-its-covid-19-vaccine-on-pre-clinical-models Click here to learn more about Applied DNA’s proprietary linear DNA production capabilities for DNA vaccines: https://www.wshu.org/post/covid-19-brings-dna-vaccines-forefront About Takis Biotech Takis is a Biotech Company created by a group of scientists from Merck Research Laboratories (MRL). The group has more than 15 years of experience and an established track record in drug discovery in Oncology and is recognized for the conception and implementation of a number of innovative technologies. One of the main assets of Takis is the expertise in in vivo electro-gene-transfer, which can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis pipeline include four Cancer Vaccine candidates based on this technology. Takis is also actively involved in the generation of humanized monoclonal antibodies for use in Oncology and Infectious Diseases. Visit www.takisbiotech.it for more information. About Applied DNA Sciences Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, diagnostics and pre-clinical nucleic acid-based therapeutic drug candidates. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list. Common stock listed on NASDAQ under the symbol APDN. Web: www.adnas.com | twitter: @APDN

Italy Ministry of Health Investments

3 Investments

Italy Ministry of Health has made 3 investments. Their latest investment was in Jointly as part of their Biz Plan Competition on November 11, 2017.

CBI Logo

Italy Ministry of Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2017

Biz Plan Competition

Jointly

Yes

1

5/9/2017

Grant - II

Subscribe to see more

$99M

Subscribe to see more

0

6/7/2016

Grant

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/8/2017

5/9/2017

6/7/2016

Round

Biz Plan Competition

Grant - II

Grant

Company

Jointly

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.